ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation (PERISCOPE)

This study has been completed.
Study NCT00225277.   Last updated on May 9, 2008.   Information provided by Takeda Global Research & Development Center, Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Diabetes Mellitus, Type 2
Coronary Artery Disease
2 Additional conditions recognized in this trial
Diabetes Mellitus
3 More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Coronary Disease
Endocrine System Diseases
Glucose Metabolism Disorders
Heart Diseases
Metabolic Diseases
Myocardial Ischemia
Vascular Diseases
4 Interventions listed in this trial
pioglitazone HCl
glimepiride
5 Additional drug interventions recognized in this trial
Pioglitazone
6 More general drug interventions related to this trial
Anti-Arrhythmia Agents
Cardiovascular Agents
Hypoglycemic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
7 Sponsors listed in this trial
Takeda Global Research &Development Center, Inc.
The Cleveland Clinic




Links to all studies - primarily for crawlers